Policy perspective reports on new global health initiatives targeting fungal disease and antifungal resistance, highlighting efforts to address critical gaps in worldwide surveillance.
Fungal disease and antifungal resistance are growing, historically underrecognized global threats that are difficult to detect and track. In this News and Perspectives article, JMIR Correspondent Sara Novak reports on two recent policy and digital health initiatives that aim to improve surveillance and close critical gaps in the global response to these public health concerns.
No takes yet. Share an insight, caveat, or question.
Sara Novak (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: